Form 4: Amedisys Inc. Executive Reports Stock Transactions

Denise M. Bohnert, Chief Compliance Officer of Amedisys Inc., reports changes in beneficial ownership of company stock due to tax withholding on vested shares and holdings in a 401(k) plan.

Summary

• On February 20, 2025, Denise M. Bohnert, Chief Compliance Officer of Amedisys Inc., had 1,083 shares of common stock disposed of to cover tax obligations.
• The transaction was automatically triggered to cover taxes on vested shares at a price of $91.09 per share.
• Following the transaction, Bohnert directly owns 19,927 shares of Amedisys Inc.
• Bohnert also indirectly owns 214 shares through a 401(k) plan, based on a plan statement dated December 31, 2024.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment, as it's simply a report of facts.

Industry Context

This Form 4 filing is a routine disclosure required by the SEC when company insiders, like the Chief Compliance Officer in this case, engage in transactions involving the company's stock. It provides transparency to the market regarding insider activity.

Stakeholder Impact

• The filing provides transparency to shareholders regarding insider transactions.

Key Dates

Keywords

Amedisys, Beneficial Ownership, Form 4, Stock Transaction, Insider Trading, SEC Filing, AMED, Bohnert, Compliance Officer